Top Markets
Coin of the day
DNA Chip Research Inc. DNA Chip Research Inc.

DNA Chip Research Inc.

2397
Kedudukan dalam Saham #25566
Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the... Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the creation of DNA microarrays. Its operations encompass research and development, bespoke contract research, and comprehensive diagnostic assistance. A notable product is the Tbone EX Kit, supplied to forensic laboratories across Japan, including those within law enforcement agencies and academic institutions. Furthermore, the company is behind the development of the EGFR (epidermal growth factor receptor) Liquid gene analysis software, a diagnostic tool designed to identify mutations in the EGFR-encoding gene from DNA harvested from plasma or cancerous tissues. This software also assesses the effectiveness of EGFR tyrosine kinase inhibitors for individuals suffering from non-small cell lung cancer. Beyond this, they are actively engaged in creating a comprehensive gene panel for cancer screening through advanced sequencing technologies. Established in 1999, the firm operates out of Tokyo, Japan.
Harga Saham
$7.12
Disegerakkan terakhir: 2025-06-18
Modal Pasaran
$48.17M
Perubahan (1 hari)
-5.48%
Perubahan (1 tahun)
0.00%
Negara
JP
Perdagangan DNA Chip Research Inc. (2397)

Kategori

Hasil untuk DNA Chip Research Inc. (2397)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada DNA Chip Research Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi DNA Chip Research Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$7.23B -
US